What Is GHRP-2? Uses, Benefits, Safety, FDA Status, and Evidence
Medical review note: This article is for educational purposes only and does not provide medical advice. GHRP-2 is not FDA-approved for human therapeutic use in the United States. Products sold online as GHRP-2, pralmorelin, or “research use only” GHRP-2 may carry serious safety, quality, and legal risks.
Quick answer
GHRP-2, also called growth hormone-releasing peptide-2 or pralmorelin, is a synthetic growth hormone secretagogue. It stimulates the pituitary gland to release growth hormone by acting through ghrelin-related growth hormone secretagogue receptor pathways. Human studies show that GHRP-2 can increase growth hormone secretion, but it is not FDA-approved in the United States, has limited clinical-outcome evidence for wellness claims, and is prohibited in competitive sport. FDA also says compounded drugs containing GHRP-2 for injectable and nasal administration may pose immunogenicity risks because of potential aggregation, peptide-related impurities, and the complexity of peptide characterization.
Key facts about GHRP-2
| Question | Answer |
|---|---|
| What is GHRP-2? | A synthetic growth hormone-releasing peptide and growth hormone secretagogue. |
| Other names | Pralmorelin, growth hormone-releasing peptide-2, KP-102, KP-102D, GPA-748. |
| Peptide class | Growth hormone secretagogue / ghrelin receptor agonist / GH-releasing peptide. |
| Main mechanism | Activates ghrelin-related growth hormone secretagogue receptor pathways to stimulate pituitary growth hormone release. |
| FDA-approved? | No. GHRP-2 is not FDA-approved in the United States. |
| Main studied uses | Growth hormone stimulation, diagnostic testing for growth hormone deficiency, short-stature research, and endocrine research. |
| Human evidence level | Limited human evidence showing GH release; weak evidence for anti-aging, fat-loss, muscle-building, sleep, and recovery claims. |
| Animal/lab evidence level | Preclinical and endocrine research supports growth hormone secretagogue activity. |
| Common online claims | “Increases HGH,” “fat loss,” “muscle growth,” “recovery,” “anti-aging,” “better sleep,” “body recomposition.” |
| Sports status | Prohibited by WADA as a growth hormone-releasing peptide. |
| Main safety concern | FDA-identified concerns around immunogenicity, aggregation, peptide-related impurities, unnatural amino acid complexity, API characterization, and unapproved online products. |
What is GHRP-2?
GHRP-2 is a synthetic peptide that stimulates growth hormone release. It belongs to the growth hormone-releasing peptide family, which also includes GHRP-6 and hexarelin.
GHRP-2 is also known as pralmorelin. It has been studied as a diagnostic growth hormone stimulation agent and as a growth hormone secretagogue.
A PubMed-indexed review of pralmorelin describes pralmorelin as GHRP-2 and identifies it as an orally active synthetic growth hormone-releasing peptide.
Another PubMed-indexed human study describes GHRP-2 as a synthetic agonist of ghrelin, the gut peptide that binds to the growth hormone secretagogue receptor.
The key distinction:
GHRP-2 can stimulate growth hormone release, but that does not make it an FDA-approved anti-aging, fat-loss, muscle-building, or recovery treatment.
How does GHRP-2 work?
GHRP-2 works through the growth hormone secretagogue receptor, also called the ghrelin receptor or GHSR.
Ghrelin is a hormone involved in appetite, metabolism, and growth hormone release. GHRP-2 mimics some ghrelin-like signaling and stimulates the pituitary gland to release growth hormone.
In plain English:
GHRP-2 tells the body to release more of its own growth hormone rather than directly supplying recombinant human growth hormone.
A PMC article on GHRP-2 and ghrelin-like activity states that GHRP-2 is a synthetic agonist of ghrelin and binds to the growth hormone secretagogue receptor.
But mechanism is not proof.
A proposed hormonal mechanism does not prove that GHRP-2 reverses aging, builds muscle, burns fat, improves sleep, accelerates recovery, heals injuries, or safely improves performance in healthy adults. The quality of evidence depends on controlled human studies in the specific population and outcome being claimed.
What is GHRP-2 used for?
GHRP-2 is commonly discussed for growth hormone stimulation, anti-aging, fat loss, muscle gain, recovery, sleep, appetite, and body composition. These uses differ sharply in evidence quality.
| Use | Evidence level | What is known | What is not known |
|---|---|---|---|
| Growth hormone stimulation | Human evidence | Human studies show GHRP-2 can stimulate GH secretion. | Long-term clinical utility and safety are not established for wellness use. |
| Diagnostic GH testing | Human evidence / used in some settings outside the U.S. | GHRP-2 stimulation tests have been studied for growth hormone deficiency diagnosis. | It is not FDA-approved for this use in the U.S. |
| Pediatric short-stature research | Limited historical evidence | Intranasal GHRP-2 studies showed modest growth-related effects in children with short stature. | It did not become a standard FDA-approved pediatric growth therapy in the U.S. |
| Anti-aging | Unsupported | Common clinic and online claim. | No strong evidence proves anti-aging or longevity benefits. |
| Fat loss/body composition | Weak / extrapolated | GH biology may influence body composition. | Not proven as a safe or effective fat-loss treatment in healthy adults. |
| Muscle growth/recovery | Weak / extrapolated | Often marketed to athletes and bodybuilders. | Not proven for performance or recovery, and prohibited in sport. |
| Sleep improvement | Weak | GH secretion and sleep biology overlap. | Human evidence does not establish GHRP-2 as a sleep treatment. |
| Online GHRP-2 products | High uncertainty | Often sold as research-use peptide products. | Quality, sterility, dosing, identity, and safety may be unknown. |
What does the research show?
Human evidence for growth hormone release
The clearest human evidence supports a narrow claim:
GHRP-2 can stimulate growth hormone release.
A PubMed-indexed pharmacokinetic/pharmacodynamic study studied growth hormone-releasing peptide-2 and concluded that administration of GHRP-2 represented a potential mode of therapy for children of short stature with inadequate GH secretion.
A PubMed-indexed study on intranasal GHRP-2 reported that intranasal GHRP-2 was well tolerated in the studied group and produced a modest but significant increase in growth velocity.
The practical interpretation:
GHRP-2 has human evidence for stimulating GH biology, but that is not the same as evidence for broad wellness, anti-aging, physique, or recovery benefits.
Human evidence for endocrine effects beyond GH
GHRP-2 may affect more than growth hormone.
A PubMed-indexed study comparing GHRP-2 and hexarelin reported that, in humans, GHRP-2 and hexarelin induced similar increases in prolactin, ACTH, and cortisol.
The practical interpretation:
GHRP-2 is not necessarily a perfectly clean GH-only signal. It can affect other endocrine pathways, which matters for safety and side effects.
Diagnostic research
GHRP-2 stimulation testing has been studied for growth hormone deficiency.
A 2022 PubMed-indexed review examined the clinical usefulness of the GHRP-2 test for diagnosis of growth hormone deficiency and noted that GHRP-2 testing is widely used in some contexts for diagnosing patients with GHD.
A 2024 PubMed-indexed study examined growth hormone responses to the GHRP-2 test in adolescents.
The practical interpretation:
GHRP-2 has legitimate endocrine research history, especially around GH stimulation testing, but this does not justify unsupported consumer peptide claims.
Evidence limitations
The FDA has raised concerns about GHRP-2 in the compounding context.
The FDA page on bulk drug substances that may present significant safety risks states that compounded drugs containing GHRP-2 for injectable and nasal administration may pose immunogenicity risk because of potential aggregation and peptide-related impurities. FDA also says GHRP-2 contains an unnatural amino acid, which adds to the complexity of peptide characterization.
The practical interpretation:
GHRP-2 should not be treated as a harmless wellness peptide. FDA has identified real safety and characterization concerns, especially for injectable and nasal compounded products.
Evidence summary
| Claim | Evidence verdict | Explanation |
|---|---|---|
| “GHRP-2 stimulates growth hormone release.” | Supported | Human studies show GHRP-2 can stimulate GH secretion. |
| “GHRP-2 is FDA-approved in the U.S.” | False | GHRP-2 is not FDA-approved in the United States. |
| “GHRP-2 is used for diagnostic GH testing.” | Supported in some non-U.S. or research contexts | GHRP-2 stimulation testing is studied and used in some settings, but that is different from U.S. FDA approval. |
| “GHRP-2 builds muscle.” | Weak / extrapolated | Often inferred from GH biology, not proven by strong clinical outcome trials. |
| “GHRP-2 burns fat.” | Weak / extrapolated | Body-composition claims are not supported by strong approval-level evidence. |
| “GHRP-2 improves sleep.” | Not established | Sleep claims are not supported by strong human clinical evidence. |
| “GHRP-2 reverses aging.” | Unsupported | Anti-aging and longevity claims are not established. |
| “GHRP-2 is safe because it is a peptide.” | False | FDA has identified immunogenicity and characterization concerns. |
| “GHRP-2 is allowed for athletes.” | False | WADA prohibits GHRP-2 as a growth hormone-releasing peptide. |
| “Research-use GHRP-2 is clinically proven.” | False | Research-use products are not FDA-approved consumer therapeutic products. |
Is GHRP-2 FDA-approved?
No. GHRP-2 is not FDA-approved in the United States.
The FDA compounding safety-risk page identifies GHRP-2 for injectable and nasal routes as a substance that may present safety risks in compounded drugs. FDA cites immunogenicity risk due to potential aggregation and peptide-related impurities, and notes that GHRP-2 contains an unnatural amino acid, which adds complexity to peptide characterization.
The key distinction:
GHRP-2 is a biologically active growth hormone secretagogue, not an FDA-approved prescription medication in the United States.
Is GHRP-2 legal?
GHRP-2’s legal status depends on product type, intended use, and jurisdiction, but the practical answer is simple:
GHRP-2 is not an FDA-approved drug in the U.S., and online availability does not mean it is legally marketed for human therapeutic use.
Some sellers market GHRP-2 as a research peptide. That does not make it safe, approved, legal, or appropriate for consumer use.
The blunt version:
Buying “research use only” GHRP-2 from an online seller is not the same as receiving an FDA-approved prescription drug from a legitimate pharmacy.
Is GHRP-2 banned in sports?
Yes. GHRP-2 is prohibited in sport.
The WADA Prohibited List includes growth hormone-releasing factors, including growth hormone secretagogues and GH-releasing peptides. The WADA 2026 Prohibited List includes GH-releasing peptides such as GHRP-2, also called pralmorelin, under prohibited substances.
For athletes, the answer is simple:
Do not use GHRP-2 if you are subject to anti-doping rules.
Safety and side effects
GHRP-2 has real biological activity. It should not be treated like a harmless supplement.
Possible or reported concerns include:
- Injection-site reactions
- Nasal irritation for intranasal products
- Headache
- Flushing
- Dizziness
- Nausea
- Increased appetite
- Water retention
- Changes in GH and IGF-1 signaling
- Possible prolactin, ACTH, and cortisol effects
- Possible glucose or metabolic effects
- Immunogenicity risk
- Peptide aggregation
- Peptide-related impurities
- Product-quality and sterility risk from online sources
- Anti-doping consequences for athletes
FDA specifically identifies immunogenicity concerns for compounded GHRP-2 for injectable and nasal routes because of possible aggregation or peptide-related impurities. FDA also notes the complexity of peptide characterization because GHRP-2 contains an unnatural amino acid.
A serious evaluation of GHRP-2 should separate controlled endocrine research from online peptide products.
GHRP-2 vs similar peptides
| Compound | Category | Main difference |
|---|---|---|
| GHRP-2 | Growth hormone-releasing peptide / ghrelin receptor agonist | Stimulates GH release through GHSR/ghrelin receptor signaling; not FDA-approved in the U.S. |
| GHRP-6 | Growth hormone-releasing peptide | Similar GH secretagogue category; often associated with stronger appetite-related claims. |
| Ipamorelin | Growth hormone secretagogue | Often described as more selective; not FDA-approved and prohibited in sport. |
| Hexarelin | Growth hormone-releasing peptide | Potent GHRP also prohibited in sport. |
| Sermorelin | GHRH analog | Works through GHRH receptor signaling; historically FDA-approved as Geref, now discontinued. |
| CJC-1295 | GHRH analog | Long-acting GHRH analog; not FDA-approved and prohibited in sport. |
| Tesamorelin | GHRH analog | FDA-approved as Egrifta products for excess abdominal fat in adults with HIV and lipodystrophy. |
| Human growth hormone | Recombinant hormone | Supplies growth hormone directly rather than stimulating endogenous release. |
The key distinction:
GHRP-2 belongs in the growth hormone secretagogue category. It is not a tissue-repair peptide, GLP-1 drug, or FDA-approved anti-aging medication.
Why is GHRP-2 sold as “research use only”?
Some online sellers use “research use only” language to sell GHRP-2 outside normal prescription-drug channels.
That label is not a trust signal.
A serious reader should understand this distinction:
| Product type | What it means |
|---|---|
| Clinical-study GHRP-2 | Controlled research product used under study conditions. |
| FDA-approved GHRP-2 in the U.S. | Does not currently exist. |
| Compounded GHRP-2 | FDA has raised safety and characterization concerns for injectable and nasal routes. |
| Research-use GHRP-2 | Not an FDA-approved consumer therapeutic product. |
| Online peptide GHRP-2 | Higher risk for identity, sterility, dosing, and quality problems. |
How to evaluate GHRP-2 claims online
| Claim | What to verify |
|---|---|
| “FDA-approved GHRP-2” | False in the U.S. GHRP-2 is not FDA-approved. |
| “Boosts HGH naturally” | It can stimulate GH release, but that does not prove broad clinical benefit. |
| “Builds muscle and burns fat” | Look for controlled human outcome trials, not just GH biomarker changes. |
| “Anti-aging peptide” | Unsupported by strong clinical evidence. |
| “Improves sleep” | Check for controlled human trials, not anecdotes. |
| “No side effects” | False. FDA has identified immunogenicity and characterization concerns. |
| “Research use only” | This does not mean safe, legal, approved, or appropriate for human use. |
| “Safe for athletes” | False. GHRP-2 is prohibited in sport. |
| “Same as sermorelin” | False. GHRP-2 works through ghrelin receptor signaling, while sermorelin is a GHRH analog. |
| “Third-party tested” | Ask for batch-specific HPLC, LC-MS, identity, purity, sterility, endotoxin, aggregate, and impurity data. |
Bottom line
GHRP-2 is a synthetic growth hormone-releasing peptide that stimulates pituitary growth hormone release through ghrelin-related growth hormone secretagogue receptor signaling. It has human evidence showing growth hormone release and legitimate endocrine research history, especially around GH stimulation testing, but it is not FDA-approved in the United States and does not have strong clinical-outcome evidence for anti-aging, fat loss, muscle growth, sleep, injury recovery, or body recomposition.
The most defensible conclusion is:
GHRP-2 is biologically active and clinically interesting, but most online wellness, physique, and anti-aging claims go beyond the strongest evidence. FDA has raised concerns about compounded GHRP-2, and athletes should avoid it because GHRP-2 is prohibited in sport.
FAQ
What is GHRP-2?
GHRP-2 is a synthetic growth hormone-releasing peptide and growth hormone secretagogue. It is also called pralmorelin.
What does GHRP-2 do?
GHRP-2 stimulates the pituitary gland to release growth hormone through ghrelin-related growth hormone secretagogue receptor signaling. This does not prove broad anti-aging, fat-loss, muscle-building, sleep, or recovery benefits.
Is GHRP-2 FDA-approved?
No. GHRP-2 is not FDA-approved in the United States. FDA has raised concerns about compounded GHRP-2 for injectable and nasal routes, including immunogenicity, aggregation, peptide-related impurities, and characterization complexity.
Is GHRP-2 the same as pralmorelin?
Yes. Pralmorelin is another name for GHRP-2.
Is GHRP-2 the same as sermorelin?
No. GHRP-2 is a ghrelin receptor agonist and growth hormone secretagogue. Sermorelin is a growth hormone-releasing hormone analog.
Is GHRP-2 the same as GHRP-6?
No. They are related growth hormone-releasing peptides, but they are different compounds with different pharmacologic profiles.
Does GHRP-2 build muscle?
Muscle-building claims are not well established. GHRP-2 can increase growth hormone release, but that does not prove safe or reliable muscle growth in healthy adults.
Does GHRP-2 burn fat?
Fat-loss claims are mostly extrapolated from growth hormone biology. GHRP-2 is not FDA-approved as a fat-loss medication.
Does GHRP-2 improve sleep?
Sleep claims are common online, but strong human clinical evidence is limited.
Is GHRP-2 safe?
GHRP-2 does not have enough long-term human safety data to call it safe for wellness use. FDA has raised concerns about immunogenicity, aggregation, peptide impurities, unnatural amino acid complexity, and characterization complexity for compounded GHRP-2.
Is GHRP-2 banned in sports?
Yes. GHRP-2 is prohibited by WADA as a growth hormone-releasing peptide.
Why do sellers call GHRP-2 “research use only”?
Sellers often use “research use only” language because GHRP-2 is not FDA-approved for consumer therapeutic use in the U.S. The phrase does not make the product safe, legal, approved, or clinically proven.
What is the biggest risk with GHRP-2?
The biggest risks are using an unapproved hormone-active peptide without medical supervision, relying on unsupported anti-aging or performance claims, and buying online products with uncertain identity, purity, sterility, concentration, and safety.
Sources
- FDA: Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks
- FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A
- PubMed: Pralmorelin, GHRP-2 Review
- PMC: GHRP-2, like ghrelin, increases food intake in healthy men
- PubMed: GHRP-2, like ghrelin, increases food intake in healthy men
- PubMed: Pharmacokinetics and pharmacodynamics of GHRP-2
- PubMed: Treatment effects of intranasal GHRP-2
- PubMed: Effects of GHRP-2 and hexarelin in humans
- PubMed: Clinical usefulness of the GHRP-2 test for GHD
- PubMed: Robust GH responses to GHRP-2 testing in adolescents
- WADA: 2026 Prohibited List
- WADA: Prohibited List
Frequently asked questions
What is GHRP-2?
GHRP-2 is a synthetic growth hormone-releasing peptide and growth hormone secretagogue. It is also called pralmorelin.
Is GHRP-2 FDA-approved?
No. GHRP-2 is not FDA-approved in the United States. FDA has raised concerns about compounded GHRP-2 for injectable and nasal routes, including immunogenicity, aggregation, peptide-related impurities, and characterization complexity.
Is GHRP-2 the same as pralmorelin?
Yes. Pralmorelin is another name for GHRP-2.
Is GHRP-2 the same as sermorelin?
No. GHRP-2 is a ghrelin receptor agonist and growth hormone secretagogue. Sermorelin is a growth hormone-releasing hormone analog.
Does GHRP-2 build muscle?
Muscle-building claims are not well established. GHRP-2 can increase growth hormone release, but that does not prove safe or reliable muscle growth in healthy adults.
Is GHRP-2 safe?
GHRP-2 does not have enough long-term human safety data to call it safe for wellness use. FDA has raised concerns about immunogenicity, aggregation, peptide impurities, unnatural amino acid complexity, and characterization complexity for compounded GHRP-2.
Is GHRP-2 banned in sports?
Yes. GHRP-2 is prohibited by WADA as a growth hormone-releasing peptide.
Sources
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]PubMed: Clinical usefulness of the GHRP-2 test for GHD
Clinical Review
- [10]
- [11]WADA: 2026 Prohibited List
Anti Doping
- [12]WADA: Prohibited List
Anti Doping
Last updated May 9, 2026